Literature DB >> 19062634

Sublingual drug delivery.

Tarun Goswami1, Bhaskara Jasti, Xiaoling Li.   

Abstract

The sublingual route is one of the early modes of administration for systemic drug delivery. This route avoids first-pass metabolism and affords quick drug entry into the systemic circulation. Attempts have been made to deliver various pharmacologically active agents, such as cardiovascular drugs, analgesics, and peptides, across the sublingual mucosa. In this review, the anatomical structure, blood supply, biochemical composition, transport pathways, permeation enhancement strategies, in vitro/in vivo models, and clinical investigations for the sublingual route of drug delivery is discussed.

Mesh:

Substances:

Year:  2008        PMID: 19062634     DOI: 10.1615/critrevtherdrugcarriersyst.v25.i5.20

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  5 in total

1.  Dual delivery of hydrophilic and hydrophobic drugs from chitosan/diatomaceous earth composite membranes.

Authors:  Rita López-Cebral; Guangjia Peng; Lara L Reys; Simone S Silva; Joaquim M Oliveira; Jie Chen; Tiago H Silva; Rui L Reis
Journal:  J Mater Sci Mater Med       Date:  2018-02-02       Impact factor: 3.896

2.  Robust antigen-specific humoral immune responses to sublingually delivered adenoviral vectors encoding HIV-1 Env: association with mucoadhesion and efficient penetration of the sublingual barrier.

Authors:  William Domm; Lauren Brooks; Hung Li Chung; Changyong Feng; William J Bowers; Gene Watson; James L McGrath; Stephen Dewhurst
Journal:  Vaccine       Date:  2011-07-27       Impact factor: 3.641

3.  Preclinical Safety and Pharmacokinetics of Heat Stable Oxytocin in Sublingual Fast-Dissolving Tablet Formulation.

Authors:  Changcheng Zhu; Manjari Lal
Journal:  Pharmaceutics       Date:  2022-04-28       Impact factor: 6.525

4.  Formulation and Characterization of Orally Dissolving Thin Films containing the German cockroach Blatella germanica (Bla g 2) Allergen.

Authors:  Qingqing Chen; Russell Martin; Stephen W Hoag; Robert A Wood; Hai-Quan Mao; Corinne Keet
Journal:  Int J Pharma Sci       Date:  2014 Sep-Oct

5.  Scalable flibanserin nanocrystal-based novel sublingual platform for female hypoactive sexual desire disorder: engineering, optimization adopting the desirability function approach and in vivo pharmacokinetic study.

Authors:  Marianne J Naguib; Amal I A Makhlouf
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.